p300/CBP transcriptional co-activator proteins play a central role in co-or
dinating and integrating multiple signal-dependent events with the transcri
ption apparatus, allowing the appropriate level of gene activity to occur i
n response to diverse physiological cues that influence, for example, proli
feration, differentiation and apoptosis. p300/CBP activity can be under abe
rrant control in human disease, particularly in cancer, which may inactivat
e a p300/CBP tumour-suppressor-like activity. The transcription regulating-
properties of p300 and CBP appear to be exerted through multiple mechanisms
. They act as protein bridges, thereby connecting different sequence-specif
ic transcription factors to the transcription apparatus. Providing a protei
n scaffold upon which to build a multicomponent transcriptional regulatory
complex is likely to be an important feature of p300/CBP control. Another k
ey property is the presence of histone acetyltransferase (HAT) activity, wh
ich endows p300/CBP with the capacity to influence chromatin activity by mo
dulating nucleosomal histones. Other proteins, including the p53 tumour sup
pressor, are targets for acetylation by p300/CBP. With the current intense
level of research activity, p300/CBP will continue to be in the limelight a
nd, we can be confident, yield new and important information on fundamental
processes involved in transcriptional control.